Literature DB >> 29570222

Role of soluble CD147 in psoriatic patients: A preliminary study.

Meiyan Gao1, Liqiu Liao2, Xuekun Jia1, Yehong Kuang1, Xiang Chen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29570222     DOI： 10.1111/1346-8138.14305

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  4 in total

1.  CD147 Is Essential for the Development of Psoriasis via the Induction of Th17 Cell Differentiation.

Authors:  Aoi Okubo; Youhei Uchida; Yuko Higashi; Takuya Sato; Youichi Ogawa; Akihiro Ryuge; Kenji Kadomatsu; Takuro Kanekura
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

2.  CD147 as a novel receptor in the pathogenesis of SARS-CoV-2: Is there any correlation with the risk of COVID-19 in dermatological diseases?

Authors:  Mohammad Reza Pourani; Fahimeh Abdollahimajd
Journal:  Dermatol Ther       Date:  2020-11-15       Impact factor: 3.858

3.  The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis.

Authors:  Michal A Rahat; Mirna Safieh; Elina Simanovich; Eliran Pasand; Tal Gazitt; Amir Haddad; Muna Elias; Devy Zisman
Journal:  Arthritis Res Ther       Date:  2020-10-14       Impact factor: 5.156

4.  Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway.

Authors:  Paweena Dana; Ryusho Kariya; Worachart Lert-Itthiporn; Wunchana Seubwai; Saowaluk Saisomboon; Chaisiri Wongkham; Seiji Okada; Sopit Wongkham; Kulthida Vaeteewoottacharn
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.